GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a significant focus in therapeutic studies, largely due to its remarkable impact on treating ailments such as adult-onset diabetes and weight gain. Ongoing trials have demonstrated that more than glucose management, GLP-1 drugs offer benefits for cardiovascular function a… Read More